UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | G | I | K | L | M | N | P | S | V | Y
Number of items: 29.


Abou-Sleiman, PM; Muqit, MMK; McDonald, NQ; Yang, YX; Gandhi, S; Healy, DG; Harvey, K; ... Wood, NW; + view all (2006) A heterozygous effect for PINK1 mutations in Parkinson's disease? ANNALS OF NEUROLOGY , 60 (4) pp. 414-419. 10.1002/ana.20960.


Badin, RA; Lythgoe, MF; van der Weerd, L; Thomas, DL; Gadian, DG; Latchman, DS; (2006) Neuroprotective effects of virally delivered HSPs in experimental stroke. J CEREBR BLOOD F MET , 26 (3) 371 - 381. 10.1038/sj.jcbfm.9600190.

Barry, SP; Townsend, PA; Latchman, DS; Stephanou, A; (2006) Role of the JAK-STAT pathway in myocardial injury. Trends Mol Med

Budhram-Mahadeo, V; Djamgoz, MBA; Latchman, DS; (2006) Brn-3a neuronal transcription factor functional expression in human prostate cancer. Prostate Cancer and Prostatic Diseases , 9 (1) pp. 83-91. 10.1038/sj.pcan.4500837.

Budhram-Mahadeo, VS; Bowen, S; Lee, S; Perez-Sanchez, C; Ensor, E; Morris, PJ; Latchman, DS; (2006) Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression. Nucleic Acids Research , 34 (22) pp. 6640-6652. 10.1093/nar/gkl878. Green open access

Budhram-Mahadeo, VS; Latchman, DS; (2006) Targeting Brn-3b in breast cancer therapy. EXPERT OPINION ON THERAPEUTIC TARGETS , 10 (1) pp. 15-25. 10.1517/14728222.10.1.15.


Calissano, M; Diss, J; Latchman, D; (2006) Post-transcriptional regulation of the Brn-3b transcription factor. In: FEBS JOURNAL. (pp. 142 - 142). BLACKWELL PUBLISHING

Carrey, EA; Synesiou, E; Simmonds, HA; Fairbanks, LD; (2006) The novel nucleotide 4KNTP, in high concentrations in erythrocytes of renal failure children: A comparison with accumulation of other putative precursors in the plasma. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , 25 (9-11) 1051 - 1054. 10.1080/15257770600890947.


Diss, J; Calissano, M; Djamgoz, M; Latchman, D; (2006) Identifying the promoter region of the human Nav1.7 voltage-gated sodium channel gene (scn9a). In: FEBS JOURNAL. (pp. 109 - 109). BLACKWELL PUBLISHING

Diss, JKJ; Faulkes, DJ; Walker, MM; Patel, A; Foster, CS; Budhram-Mahadeo, V; Djamgoz, MBA; (2006) Brn-3a neuronal transcription factor functional expression in human prostate cancer. Prostate Cancer and Prostatic Diseases , 9 pp. 83-91.


Francis, YI; Stephanou, A; Latchman, DS; (2006) CREB-binding protein activation by presenilin 1 but not by its M146L mutant. NEUROREPORT , 17 (9) 917 - 921.


Gandhi, S; Muqit, MMK; Stanyer, L; Healy, DG; Abou-Sleiman, PM; Hargreaves, I; Heales, S; ... Revesz, T; + view all (2006) PINK1 protein in normal human brain and Parkinson's disease. BRAIN , 129 1720 - 1731. 10.1093/brain/awl114.

Giles, I; Lambrianides, N; Pattni, N; Faulkes, D; Latchman, D; Chen, PJ; Pierangeli, S; ... Rahman, A; + view all (2006) Arginine residues are important in determining the binding of human monoclonal antiphospholipid antibodies to clinically relevant antigens. J IMMUNOL , 177 (3) 1729 - 1736.

Giles, I; Liu, X; Newton-West, M; Swerlick, R; Lambranides, A; Chen, P; Latchman, D; ... Pierangeli, S; + view all (2006) The light chain of a human monoclonal antiphospholipid antibody has a dramatic influence on its functional properties in an in vivo mouse model. In: ARTHRITIS AND RHEUMATISM. (pp. S559 - S559). WILEY-LISS


Ioannou, Y; Giles, I; Lambrianides, A; Richardson, C; Pearl, LH; Latchman, DS; Isenberg, DA; (2006) A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli. BMC Biotechnology , 6 , Article 8. 10.1186/1472-6750-6-8. Green open access


Kabakov, AE; Malyutina, YV; Latchman, DS; (2006) Hsf1-mediated stress response can transiently enhance cellular radioresistance. Radiation Research , 165 (4) pp. 410-423.


Lawrence, KM; Latchman, DS; (2006) The urocortins: Mechanisms of cardioprotection and therapeutic potential. MINI-REVIEWS IN MEDICINAL CHEMISTRY , 6 (10) pp. 1119-1126. 10.2174/138955706778560111.


Muqit, MMK; Abou-Sleiman, PM; Saurin, AT; Harvey, K; Gandhi, S; Deas, E; Eaton, S; ... Latchman, DS; + view all (2006) Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J NEUROCHEM , 98 (1) 156 - 169. 10.1111/j.1471-4159.2006.03845.x.


Ndisang, D; Faulkes, DJ; Gascoyne, D; Lee, SA; Ripley, BJ; Sindos, M; Singer, A; ... Latchman, DS; + view all (2006) Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a. ONCOGENE , 25 (1) 51 - 60. 10.1038/sj.onc.1209006.

Ndisang, D; Lorenzato, F; Sindos, M; Singer, A; Latchman, DS; (2006) Detection of cervical abnormalities in a developing country using measurement of Brn-3a in cervical smears. Gynecol Oncol. , 100 (1) pp. 89-94.


Pericleous, C; Ioannou, Y; Lambrianides, A; Chen, P; Latchman, D; Isenberg, D; Rahman, A; (2006) Exploring the nature of the interaction between human monoclonal antiphospholipid antibodies and domain I of ss 2-glycoprotein I. In: ARTHRITIS AND RHEUMATISM. (pp. S559 - S560). WILEY-LISS

Peters, GJ; Carrey, EA; Sebesta, I; (2006) Purine and pyrimidine metabolism: A firm basis for a transformed society. NUCLEOS NUCLEOT NUCL , 25 (9-11) 971 - 974. 10.1080/15257770600887166.


Samady, L; Faulkes, DJ; Budhram-Mahadeo, V; Ndisang, D; Potter, E; Brabant, G; Latchman, DS; (2006) The Brn-3b POU family transcription factor represses plakoglobin gene expression in human breast cancer cells. International Journal of Cancer , 118 (4) pp. 869-878.

Samady, L; Faulkes, DJ; Budhram-Mahadeo, V; Ndisang, D; Potter, E; Brabant, G; Latchman, DS; (2006) The Brn-3b POU family transcription factor represses plakoglobin gene expression in human breast cancer cells. INT J CANCER , 118 (4) 869 - 878. 10.1002/ijc.21435.

Scarabelli, TM; Knight, R; Stephanou, A; Townsend, P; Chen-Scarabelli, C; Lawrence, K; Gottlieb, R; ... Narula, J; + view all (2006) Clinical implications of apoptosis in ischemic myocardium. CURR PROB CARDIOLOGY , 31 (3) 181 - 264. 10.1016/j.cpcardiol.2005.11.002.

Slominska, EM; Carrey, EA; Foks, H; Orlewska, C; Wieczerzak, E; Sowinski, P; Yacoub, MH; ... Smolenski, RT; + view all (2006) A novel nucleotide found in human erythrocytes, 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate. J BIOL CHEM , 281 (43) 32057 - 32064. 10.1074/jbc.M607514200. Gold open access

Smart, N; Mojet, MH; Latchman, DS; Marber, MS; Duchen, MR; Heads, RJ; (2006) IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes. CARDIOVASC RES , 69 (1) 164 - 177. 10.1016/j.cardiores.2005.08.017.


Valentim, L; Lawrence, KM; Townsend, PA; Carroll, CJ; Soond, S; Scarabelli, TM; Knight, RA; ... Stephanou, A; + view all (2006) Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J MOL CELL CARDIOL , 40 (6) 846 - 852. 10.1016/j.yjmcc.2006.03.428.


Yang, YX; Muqit, MMK; Latchman, DS; (2006) Induction of parkin expression in the presence of oxidative stress. European Journal of Neuroscience , 24 (5) pp. 1366-1372.

This list was generated on Sun Feb 3 07:30:44 2019 GMT.